Revolution Medicines

Role Description The Director, Global Business Systems Enablement is responsible for defining, establishing, and evolving the operating model that enables Commercial, Medical Affairs, and selected G&A global business systems across markets outside the United States. This role ensures that regional needs are clearly understood, refined, and effectively integrated into scalable global processes and governance. - Lead the Go-to-Market and selected G&A business systems workstream for Global Markets (outside of the United States). - Provide strategic leadership, governance, coordination, and visibility across regional initiatives. - Translate regional business needs into executable work in partnership with global solution teams. - Drive effective qualification and prioritization of ex US demand before it enters global intake forums. Qualifications - Bachelor’s degree required (or equivalent). - 12+ years of experience supporting enterprise business systems, including Commercial, Medical, Finance/ERP, IT business partnership, business transformation, program management, or related disciplines. - Experience supporting global or multi-regional initiatives, preferably across Europe and Asia Pacific. - Demonstrated experience designing or evolving global operating models, governance frameworks, or organizational processes. - Strong understanding of commercialization processes, launch readiness, and enterprise business systems and data sources. - Excellent stakeholder management, communication, and organizational skills. - Proven ability to build trust and manage relationships across multiple functions. - Understanding of regional data privacy and compliance regulations and processes. - Highly organized with strong attention to detail and commitment to quality outcomes. - Collaborative, adaptable, and effective in building rapport across global, regional, and functional teams. Requirements - Demonstrated ability to influence senior leaders and lead without direct authority across highly matrixed global organizations. - Demonstrated understanding of how AI, analytics, automation, and emerging technologies can be applied to improve commercial operations. - Experience leading organizational change, business transformation, or large-scale process improvement initiatives. - Ability to manage a portfolio of initiatives simultaneously and independently. - Thrives in fast-paced, high-growth, and rapidly changing environments. - Comfortable with ambiguity and skilled at defining operating models, processes, and roles. Benefits - Base pay salary range: $211,000 — $264,000 USD. - Competitive cash compensation. - Robust equity awards. - Strong benefits. - Significant learning and development opportunities.

Role Description As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. This is a rare and highly visible opportunity to help build something new at a pivotal moment in Revolution Medicines' growth. We are seeking an experienced and highly collaborative Executive Director, Global Commercialization Effectiveness to play a foundational role in establishing and scaling commercialization effectiveness as a core capability within the Global Commercialization organization. This role sits within the newly formed Commercialization Effectiveness & Operations (CE&O) function and will be accountable for commercialization operations, project management, organizational effectiveness, and cross-functional integration across the commercialization organization. You will partner closely with: - Global Commercial Leads - Global Medical Leads - Global Market Access Leads - Regional leadership teams - Other cross-functional stakeholders You will define and continuously evolve the Global Commercialization operating model, ensuring effective integration across: - Commercial - Medical Affairs - Market Access - Regional organizations The role will establish scalable frameworks, planning processes, governance structures, and organizational capabilities that strengthen execution and support future growth. Operating in a build-while-scaling environment, this leader will help shape how complex, cross-functional work gets done - bringing clarity, structure, and momentum while partnering closely with senior leaders across the organization. As the capability matures, this leader will build and lead a multidisciplinary organization spanning commercialization operations, project management, governance, planning, and organizational effectiveness. What You’ll Do - Serve as the primary integration leader across Global Commercial, Global Medical Affairs, Global Market Access, Regional Commercial Operations, and key corporate functions to ensure aligned planning, prioritization, and execution. - Define and evolve the Global Commercialization operating model, establishing scalable frameworks that enable execution excellence and organizational effectiveness. - Provide project management leadership and oversight for Global Commercialization Teams and Global Commercial Teams, ensuring alignment, accountability, and progress across strategic priorities through scalable project management capabilities and teams. - Maintain overall accountability for execution across a portfolio of high-priority global commercial and commercialization initiatives, ensuring milestones, risks, dependencies, and decisions are effectively managed through appropriate governance, operating processes, and team leadership. - Manage commercialization governance and planning processes, ensuring effective prioritization, resource allocation, decision-making, and escalation pathways across the commercialization organization. - Build and scale commercialization effectiveness capabilities, including project management, operations, governance, planning, tools, dashboards, and performance management processes. - Provide direct operational support to Global Commercial and Market Access organizations, ensuring efficient planning cycles, operational discipline, and execution consistency. - Lead change adoption efforts related to new tools, processes, and ways of working, ensuring sustainable implementation across a global organization. - Recruit, develop, and lead a high-performing team, creating scalable capabilities and ways of working that support the future needs of the organization. Qualifications - Bachelor's degree with 12+ years of relevant experience in biotech, pharmaceutical or healthcare industry, including significant experience leading complex commercial or commercialization initiatives. - Experience supporting global commercialization organizations, including involvement in launch readiness, operational planning, or capability buildout. - Experience working across global and regional operating models, with demonstrated ability to drive alignment across geographies. - Demonstrated Executive Director-level capability, including defining operating models, building scalable organizational capabilities, and driving cross-functional alignment in evolving organizations. - Strong operational leadership skills, including process design, governance, performance management, and cross-functional coordination. - Proven success partnering with senior commercial, medical, and access leaders to enable organizational effectiveness. - Experience building and scaling high-performing teams and organizational capabilities. - Track record of thriving in ambiguous, fast-moving environments with a hands-on, builder mindset. - Exceptional communication and interpersonal skills, with the ability to translate complexity into clear and actionable frameworks. - Strong systems thinking, judgment, and a continuous improvement mindset. Preferred Skills - Advanced degree (MBA/MS/PhD). - Oncology / specialty pharma commercialization experience. - Experience building and leading commercialization operations, PMO, organizational effectiveness, or business operations functions. Benefits - Competitive cash compensation - Robust equity awards - Strong benefits - Significant learning and development opportunities Base Pay Salary Range $252,000 — $315,000 USD

Role Description We are seeking a highly motivated and experienced professional to join our team as a Medical Science Liaison, Netherlands. Key aspects of this role will include: - Engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights. - Serve as a therapeutic expert and thought partner to internal teams. - Liaison between Revolution Medicines and clinical study sites / investigators. - Provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for: - Cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases of product development. - Collaborating with stakeholders within medical affairs and across the organization, including but not limited to Clinical Development, Commercial, Program Management, Clinical Operations, and Compliance teams. The ideal candidate is an effective communicator, driven, detail-oriented, proactive, and a skilled collaborator. Qualifications - Doctoral degree in scientific or medical discipline. - 8+ years experience as an MSL or in a similar role within the pharmaceutical or biotech industry in Netherlands. - Strong understanding of clinical research methodologies and drug development processes. - Knowledge and experience within the oncology therapeutic area, preferred experience in lung and gastrointestinal cancers. - Excellent verbal and written communication skills. - Proven ability to analyze and synthesize scientific information effectively. - Excellent presentation skills, with the ability to effectively communicate complex scientific data to diverse audiences. - Strong networking skills with proven ability to successfully build and maintain relationships with KOLs and healthcare professionals. - Self-directed and able to thrive in a fast-paced and dynamic environment. - Willingness to travel up to 60% of time. Requirements - Develop and maintain strong relationships with KOLs, healthcare professionals, and academic institutions to advance scientific and medical knowledge. - Communicate clinical and scientific data to KOLs and healthcare professionals through presentations, educational programs, and scientific discussions. - Support the synthesis and communicate scientific insights from KOLs to relevant internal teams. - Provide scientific support for medical congresses, advisory boards and other relevant scientific engagements to enhance the visibility of RevMed within the scientific and medical communities. - Establish credibility as a scientific expert and resource for internal stakeholders, providing medical and scientific support for products and therapeutic areas. - Collaborate cross-functionally with medical affairs, clinical development, marketing and other teams to support the development and execution of medical strategies and tactics. - Stay current with scientific literature, emerging research, and competitive landscape. - Adhere to Revolution Medicines Core Values and policies. - Understand the regulatory requirements for customer engagement by field-based employees. Company Description Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), elironrasib (RMC-6291), zoldonrasib (RMC-9805), and RMC-5127 are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Role Description RevMed is seeking an experienced compliance leader in Europe. As a key member of the Legal and Compliance function, this is an excellent opportunity to lead a team and support the launch of new RevMed therapies and the Company’s rapid business growth in Europe. The position will contribute to the development and implementation of organizational strategies, policies and practices, and work with senior Commercial, Medical, Clinical Development, Legal, Finance and HR leadership to integrate appropriate healthcare, corporate and other compliance controls to guide the Company’s operations. Key Responsibilities - Lead continuous development of Healthcare Compliance Programs in Europe in line with RevMed’s global compliance strategy, the OIG Compliance Program Guidance for Pharmaceutical Manufactures (OIG Guidance), applicable industry codes and best practices. - Build and manage a team of European Compliance Officers to support country specific business departments. - Lead the buildout of European Compliance Operations to support European business initiatives. - Represent Compliance as the Compliance lead on the European Leadership team. - Collaborate with cross-regions and implement global compliance initiatives in Europe. - Proactively identify legal and regulatory issues, industry trends, industry codes and practices applicable to compliance. - Advise on the adoption of new, or revision of existing, policies and procedures to ensure compliance with laws, regulations and applicable industry codes globally and regionally. - Develop and monitor the execution of a comprehensive compliance training program for Europe employees and designated third parties on applicable compliance policies, laws and regulations. - Foster a culture of compliance and integrity in the region. - Provide compliance leadership and oversight for review and approval processes for core Commercial and Medical activities: grants, sponsorships, speaker bureau, advisory boards and other initiatives involving interactions with healthcare professionals, healthcare organizations, governments, and patient advocacy groups. - Provide healthcare compliance subject matter expertise in the development of appropriate systems, tools and technology solutions to enhance the efficiency and effectiveness of the Healthcare Compliance Program relating to common HCP interactions, such as advisory boards, consulting engagements, speaker programs, sponsorships and grants. - Collaborate with the Head of Compliance on the design and execution of internal reviews, risk assessments, monitoring and auditing to ensure that compliance policies and procedures function as intended and the Company identifies potential compliance risks and remediates where necessary. - Support Head of Global Compliance in the conduct and resolution of compliance investigations as needed, including the implementation of corrective and preventive actions plans. - Establish and chair the Compliance Committee in Europe; Provide regular compliance related reports and other communications for multiple audiences in the Company, including the Compliance Committee, Commercial Leadership, Medical Affairs teams, and country management teams. - Partner with the Head of Global Compliance to build, develop, and manage the European compliance team, including hiring, onboarding, performance management, mentoring, and establishing scalable operating models to support the Company’s growth in Europe. Qualifications - Minimum of 14 years’ relevant experience including in-house pharmaceutical experience developing compliance programs. - Experience managing people, teams and dotted-line reports. - Extensive experience with compliance matters relating to the development, approval and commercialization of pharmaceutical products in Europe. - Comprehensive knowledge of healthcare fraud and abuse laws and transparency requirements as well as industry codes in European countries. - Ability to apply a risk-based analysis to compliance issues and demonstrate creativity and flexibility in developing solutions that satisfy both business requirements and legal obligations. - Strong critical thinking skills, attention to detail, adaptability, communication skills and professionalism. - Ability to work in a matrix organization, collaborate with business partners, influence peers and interact with both senior management and Field Force, Medical and Market Access teams. - Ability to manage and serve a wide range of client groups by recognizing and responding quickly and pragmatically to urgent situations. - Exceptional and demonstrated written and verbal communication skills and interpersonal skills in both one-on-one and group settings, as well as proven negotiation skills. - Excellent organizational skills and problem-solving capabilities and the ability to perform in a fast-paced, high volume, deadline-driven environment. - Confidence to advise stakeholders at all levels. - Appropriate judgment to liaise with Legal and business colleagues and/or outside counsel as needed. - Commitment to being a team player with the desire to be helpful in other areas covered by a growing Compliance department. Company Description Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), elironrasib (RMC-6291), zoldonrasib (RMC-9805), and RMC-5127 are currently in clinical development.

Role Description Revolution Medicines is seeking a Director, US Strategic Pricing to lead lifecycle price recommendations for portfolio assets including pipeline price strategies, gross-to-net and forecast inputs, as well as market access tactics with USMA colleagues, brand and finance stakeholders to maximize brand and portfolio corporate value. The Director, US Strategic Pricing will serve as a subject matter expert in US Market Access and Oncology price strategy with deep knowledge of mandated and commercial payer environments, US pricing policy and global pricing interdependences. This role can be based in Redwood City, CA location or can be remotely based with up to 15% travel. - Develop and lead life cycle list and net price recommendations for pipeline portfolio and indication sequencing pricing strategies. - Effectively partner with internal stakeholders to develop relationships to drive price strategy access including Global Market Access, Pricing, and Development, US Market Access Marketing, Field Key Account teams. - Monitor, assess and recommend pricing adjustments to support life cycle management efforts consistent with pipeline indication expansion opportunities. - Develop contract strategies and structures in close collaboration with USMA, brand and legal partners. - Ensure compliance with all applicable laws, regulations, and company policies related to pricing and contracting. Qualifications - Bachelor’s degree. - Minimum of 8 years of pharmaceutical market access experience. - 2+ years of Oncology product experience. - 6+ years pricing, and payer/provider contracting experience to support mandated and discretionary price strategies. - Extensive experience and demonstrated success in customer segment contract strategy, market knowledge, and pricing policies to support products and/or portfolio. - Strong understanding relationship within IRA policy guidelines and CMS price demonstrations. - Experience with day-to-day management of vendor partners. - Strong knowledge of trends, issues and policies influencing drug pricing and oncology market. - Ability to communicate effectively, both orally and in writing. - Ability to effectively deliver strategy and price recommendations and presentations to a variety of audience types across all levels of the organization with impact. - Embrace cross-functional collaboration with internal and external customers; possesses interpersonal skills to develop and maintain cooperative working and business relationships. - Ability to effectively resolve conflicts and multi-department alignment to delivery commercial goals and objectives. Preferred Skills - Experience with oral oncology therapies and targeted treatments for RAS-mutated cancers. - Advanced degree (MBA, MPH, or similar). Benefits - Base pay salary range: $211,000 — $264,000 USD. - Competitive cash compensation. - Robust equity awards. - Strong benefits. - Significant learning and development opportunities.

Role Description The Senior Director, HEOR/RWE is a leader within the organization, responsible for developing an HEOR/RWE strategy and executing HEOR plans and activities related to Revolution Medicines assets intended for use in pancreatic and colorectal cancer. They will be accountable for demonstrating the value of Revolution Medicines products to healthcare organizations, allowing them to make informed decisions. They will work closely with the Medical Affairs team as well as other cross-functional teams to optimize the Integrated Evidence Plan (IEP) and to deliver evidence supporting the use of Revolution Medicines products. This individual will serve as an HEOR expert internally and also while representing RevMed externally at industry conferences. Reporting to the Executive Director of HEOR/RWE GI, the Senior Director, HEOR/RWE will: - Develop and evolve product HEOR/RWE strategy, including integration with development and market access planning. - Align with Medical Affairs and Development leadership to design research and deliver evidence consistent with the medical strategy and IEP. - Deliver HEOR/RWE tactics with quality and in alignment with agreed upon timing. - Provide HEOR/RWE leadership on matrix teams and working groups. - Lead enterprise partnerships with payers, HTA agencies, and global consortia to help shape access strategy, policies, evidence standards, and evidence generation activities. - Work with the HEOR/RWE and Medical Affairs leadership to ensure critical value insights are communicated to key internal teams. - Provide HEOR evidence which addresses the needs and expectations of key stakeholders such as patients, healthcare providers, payers and Health Technology Assessment (HTA) agencies. - Effectively present research findings to internal and external stakeholders to improve internal decision making and to promote wider adoption of research findings across external stakeholders. - Facilitate the communication of the value proposition of Revolution Medicines’ portfolio, allowing key healthcare and formulary professionals to make informed therapeutic decisions. - Engage and collaborate with external partners including payers, health care providers, thought leaders, patient advocates, and decision-makers to establish/maintain strong partnerships and gather insights into research programs. - Facilitate and implement real-world research partnership engagements with leading healthcare, academic and payer organizations to co-create value evidence and help drive evidence-based optimal care. - Stay up to date with and add to the advancements in health economics methodologies and best practices; support the build of disease area HEOR/RWE disease area capability, establishing best practices, external visibility, and functional excellence across the medical affairs network. - Identify and interface with HEOR & RWE experts and organizations, profile data sources and related organizations as they relate to Revolution Medicines’ portfolio and therapeutic areas. - Closely monitor new trends in health policy and payer environment, assess competitive data gaps and communicate to the organization, to help Revolution Medicines build industry-leading capabilities and be on the cutting edge of evidence-based medicine and HEOR research. Qualifications - Deep expertise in health economics, outcomes research, patient-reported outcomes or related fields in the biotechnology or pharmaceutical industry. - Experience in oncology HEOR and RWE development. - Minimum 10-13 years of relevant experience with an advanced degree in a relevant field (MD, PhD, PharmD). - Track record of high impact publications in HEOR/RWE topics. - Proven success influencing payer/HTA strategy and incorporating HEOR considerations into clinical development programs. - Strong written and interpersonal communication skills, with an ability to present complex technical information clearly. - Demonstrated ability to lead evidence generation initiatives and to communicate HEOR value to internal senior leadership and external decision-makers. - Knowledge and experience in managed care, integrated delivery networks, formulary decision-making, and payment/access models. - Ability to establish relationships with experts in real world evidence (RWE) and therapeutic areas of interest. Preferred Skills - 10+ years of relevant experience in the pharmaceutical/biotech industry. - Global launch experience. - Experience related to gastrointestinal oncology.

Role Description We are seeking a highly motivated field medical professional to join our team as Medical Science Liaison, Oncology, UK. This role will execute approved field medical plans within an assigned UK territory, engage in peer-to-peer scientific exchange with healthcare professionals, gather and communicate medical insights, support clinical study site and investigator engagement, and contribute to medical education, advisory boards, and congress activities under the direction of the Medical Director, UK. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for: - Cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases of product development. - Collaborating with stakeholders within medical affairs and across the organization, including but not limited to Clinical Development, Commercial, Program Management, Clinical Operations, and Compliance teams. The ideal candidate is an effective communicator, driven, detail-oriented, proactive, and a skilled collaborator. The role is an individual contributor position with no direct line-management accountability. The MSL contributes field insights and scientific expertise to support the Swiss medical plan but does not own country medical strategy, governance, budget, or team leadership. Qualifications - Advanced life science degree (PhD, MPharm, MD, or MSc). - 8+ years of relevant experience in Medical Affairs, Field Medical, Clinical Development, or a similar role within the pharmaceutical or biotech industry; prior MSL experience in Switzerland strongly preferred. - Proven experience as an MSL or similar medical affairs role, ideally within oncology. - Strong understanding of clinical research methodologies and drug development processes. - Knowledge and experience within the oncology therapeutic area, preferred experience in lung and gastrointestinal cancers. - Excellent verbal and written communication skills. - Proven ability to analyse and synthesize scientific information effectively. - Excellent presentation skills, with the ability to effectively communicate complex scientific data to diverse audiences. - Strong networking skills with proven ability to successfully build and maintain relationships with KOLs and healthcare professionals. - Self-directed and able to thrive in a fast-paced and dynamic environment. - Willingness to travel up to 60% of time. Requirements - Develop and maintain strong relationships with KOLs, healthcare professionals, and academic institutions to advance scientific and medical knowledge. - Communicate clinical and scientific data to KOLs and healthcare professionals through presentations, educational programs, and scientific discussions. - Collect, document, synthesise, and communicate field medical insights from KOLs and HCPs to the Medical Director and relevant internal teams. - Provide scientific support for medical congresses, advisory boards, and other relevant scientific engagements to enhance the visibility of Revolution Medicines within the scientific and medical communities. - Establish credibility as a scientific expert and resource for internal stakeholders, providing medical and scientific support for assigned products and therapeutic areas and territory. - Collaborate cross-functionally with Medical Affairs, Clinical Development, Commercial, Clinical Operations, and Compliance to support execution of approved medical strategies and tactics. - Stay current with scientific literature, emerging research, and competitive landscape. - Adhere to Revolution Medicines Core Values and policies. - Understand the regulatory requirements for customer engagement by field-based employees. - Develop and execute the field medical engagement plan for assigned accounts and stakeholders. - Maintain high-quality documentation of scientific interactions and insights in accordance with company systems and compliance requirements. - Support onboarding and informal coaching of new field medical colleagues, where appropriate. - Provide territory-level input to medical planning, launch readiness, and external engagement priorities. Benefits - Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. - We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy.

Role Description The Senior Director, Head of Search & Evaluation is a senior leader within the Business Development organization responsible for identifying, assessing, and advancing external innovation opportunities that support Revolution Medicines' portfolio strategy and long-term growth objectives. - Work in close partnership with leaders across Research, Development, Commercial, Corporate Strategy, Portfolio Management, and Executive Management. - Lead the company's search and evaluation activities across discovery and clinical-stage opportunities. - Accountable for developing and maintaining a robust pipeline of external opportunities. - Drive rigorous opportunity assessments and provide strategic recommendations that inform portfolio and partnering decisions. - Serve as a key connector across the organization to align external innovation efforts with corporate strategy and therapeutic area priorities. Qualifications - Advanced scientific degree (PhD, MD, PharmD, or equivalent) in a relevant life sciences discipline strongly preferred; MBA or other business training is a plus. - 12+ years of experience in biotechnology, pharmaceutical, business development, corporate strategy, research, venture investing, consulting, or related disciplines. - Significant experience evaluating external innovation opportunities across discovery and clinical-stage development. - Deep understanding of oncology drug development, precision medicine, translational science, and the biopharmaceutical development process. - Demonstrated experience leading cross-functional diligence efforts and developing recommendations for senior leadership. - Strong strategic thinking and ability to connect scientific innovation with portfolio and business objectives. - Experience leading highly matrixed teams and influencing stakeholders across multiple functions and organizational levels. - Exceptional communication, presentation, and executive influencing skills. - Proven ability to synthesize complex scientific, clinical, commercial, and financial information into actionable recommendations. Requirements - Lead the company's search and evaluation of external innovation in partnership with senior cross-functional stakeholders. - Develop and execute search strategies that align with Revolution Medicines' research, development, and commercial priorities. - Oversee all discovery- and clinical-stage search and evaluation activities. - Drive proactive opportunity sourcing through engagement with biotechnology companies, academic institutions, investors, entrepreneurs, and other innovation ecosystems. - Partner with Portfolio Management, Disease Strategy, Research, and Development leaders to identify areas for strategic value. - Maintain a comprehensive understanding of relevant scientific, clinical, and competitive landscapes. - Lead cross-functional diligence and opportunity assessments. - Establish clear evaluation frameworks and decision criteria for consistent assessment of external opportunities. - Coordinate diligence activities across various functions. - Develop balanced recommendations regarding prioritization, resource allocation, and partnership strategy. - Establish and maintain scalable frameworks for opportunity evaluation and governance. - Prepare and present opportunity assessments and strategic recommendations to senior leadership. - Partner closely with the Head of Transactions & Partnering to advance prioritized opportunities. - Build and lead a high-performing Search & Evaluation organization. - Build and maintain senior-level relationships across the biotechnology, pharmaceutical, academic, and investment communities. Benefits - Competitive salary and performance-based bonuses. - Comprehensive health benefits. - Retirement savings plan with company match. - Generous paid time off and holidays. - Opportunities for professional development and growth. Company Description Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. - Current clinical development includes daraxonrasib (RMC-6236), elironrasib (RMC-6291), zoldonrasib (RMC-9805), and RMC-5127. - Commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Role Description The Senior Director, Head of Transactions and Partnering is a senior leader within the Business Development organization responsible for leading the evaluation, structuring, negotiation, and execution of strategic business development transactions that support Revolution Medicines' corporate and portfolio objectives. This individual serves as the company's transaction lead and principal negotiator across a broad range of strategic partnerships, including: - Licensing - Collaboration - Co-development - Alliance - Option - Platform - Other business development agreements The successful candidate will bring deep transaction expertise, strong business judgment, and exceptional negotiation skills, coupled with the ability to lead complex cross-functional teams and drive alignment among diverse stakeholders. This individual will play a critical role in enabling Revolution Medicines to establish and execute strategic partnerships that accelerate innovation, expand capabilities, and create long-term value for patients and shareholders. Qualifications - Advanced degree in life sciences, medicine, pharmacy, business, or a related field; MBA, PhD, MD, PharmD preferred. - 12+ years of relevant experience in biotechnology or pharmaceutical business development, transactions, corporate strategy, or related disciplines. - Demonstrated track record of leading and executing multiple complex strategic transactions, including licensing, collaboration, co-development, alliance, acquisition, or other business development agreements. - Significant experience independently leading negotiations from initial engagement through definitive agreement execution. - Deep understanding of biopharmaceutical drug development, transaction structures, valuation methodologies, and deal economics. - Strong understanding of intellectual property considerations, licensing frameworks, and strategic partnership models within the life sciences industry. - Exceptional strategic thinking, analytical, and problem-solving skills. - Outstanding communication, presentation, and influencing capabilities, including experience presenting recommendations to senior executives. - Proven ability to lead complex cross-functional initiatives and achieve alignment without direct authority. - Ability to thrive in a fast-paced, highly collaborative, and evolving environment. Requirements - Experience supporting transactions involving oncology therapeutics, precision medicine, targeted therapies, or related technologies. - Experience within both large pharmaceutical and emerging biotechnology environments. - Established network across biotechnology, pharmaceutical, venture capital, and academic communities. - Experience supporting global transactions involving multiple geographies and stakeholders. Leadership Competencies - Executive presence and sound judgment. - Strategic thinking and business acumen. - Transaction leadership and negotiation excellence. - Collaboration and influence across matrixed organizations. - Accountability and results orientation. - Intellectual curiosity and learning agility. - Effective communication with executive and board-level audiences. - Commitment to Revolution Medicines' mission and values. External Relationship Management - Build and maintain senior-level relationships across the biotechnology, pharmaceutical, academic, and investment communities. - Represent Revolution Medicines in partnering discussions, industry conferences, and external business development engagements. - Support opportunity sourcing and relationship development efforts in partnership with Business Development leadership. - Establish a strong external network that enhances the company's access to innovative science, technologies, and strategic opportunities. Organizational Leadership - Contribute to the continued development of business development processes, transaction governance practices, and execution capabilities. - Develop and implement transaction best practices, tools, and frameworks that improve efficiency and consistency across the organization. - Promote a culture of collaboration, accountability, excellence, and integrity.

Role Description The Associate Director, Market Access, Germany is responsible for defining and executing the market access strategy to ensure timely, sustainable patient access to innovative oncology therapies. Working closely with the Senior Director, Market Access, in Germany, this role helps to shape business strategies, drives value demonstration, and leads engagement with key external stakeholders including payers, HTA bodies, and health authorities. The incumbent will partner with regional and global commercial, HEOR, and medical affairs teams to deliver launch activities by providing access insights, developing evidence-based HTA, Pricing & Reimbursement dossiers and tools, engaging with market access and public affairs stakeholders as well as participating in pricing strategy activities, and drive the activities to deliver access results supporting the overall success of the product launches. Responsibilities - Market Access & Reimbursement: Develop and implement strategies to support access and pricing decisions for oncology products within the German healthcare system. - HTA & Pricing Filings: Lead preparation and submission of value dossiers, benefit assessments (e.g., AMNOG/G-BA) and pricing negotiations with statutory health insurance decision makers (e.g., GKV-SV). - Value Communication: Translate clinical and economic evidence into compelling value communications tailored for German payers. - External Stakeholder Engagement: Build and maintain strong relationships with key external stakeholders (payers, HTA authorities, policy influencers). - Cross-Functional Collaboration: Work with Global and EU Region Market Access teams to align local access strategy with broader European and corporate objectives. - Participation in negotiations with all levels of national payers. - Collaborate with internal functions to develop innovative pricing and value-based contracting models to optimize the acceleration of reimbursement approvals. - Policy Monitoring: Monitor health policy developments, HTA processes and local reimbursement environments to inform strategy. - Drive access and value related projects such as landscape assessments, payer market research, payer advisory boards and general guidance on local strategies. - Development of outreach and engagement plan for key payers and their influencers creating and maintaining a strong network. - Participate in early access planning of new products and indications, drive launch readiness for multiple oncology assets. Qualifications - Advanced degree (e.g., PhD in Life Sciences, Pharmacy, Health Economics, Public Health). - 8+ years experience in market access, pricing, reimbursement or health economics (pharma/biotech/market access consulting). - Proven AMNOG/benefit assessment experience, with deep understanding of payer decision-making in Germany. - Demonstrated success and experience supporting an oncology product pre-launch, launch and post-launch in Germany. - Demonstrated success in negotiating pricing and reimbursement conditions with public administrations and health authorities. - Strong stakeholder management and ability to collaborate with internal and external partners. - Excellent communication skills, both in person and virtual. - Scientific and solution-oriented mindset and capability to move and execute in a rapidly changing, ambiguous environment. - Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments. - Strong commercial and strategic acumen. - Willingness to travel nationally and internationally. - Proven leadership and people management capabilities; demonstrated success in small but fast-growing, entrepreneurial commercial environment. Company Description Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors currently in clinical development include: - daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; - elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; - zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; - RMC-5127, a RAS(ON) G12V-selective inhibitor. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.